nejm tirzepatide In the SUMMIT trial, researchers examined cardiovascular outcomes of treatment with in patients with heart failure with preserved ejection fraction and obesity. Full trial results and Plain Language Summary: https://t.co/8joe2mst3e The results are finally in

eLife Sciences Publications, Ltd

Wegovy and Zepbound are FDA approved for weight loss, and Wegovy additionally received approval from the agency to treat cardiovascular conditions in patients with overweight or obesity in March

Estrogen does not just affect hair, hot flashes, or the vaginal epithelium

This matters for reading the evidence: a paper studying recombinant full-length T4 is not automatically evidence about a fragment sold as TB-500, and product labeling in the research-chemical channel is inconsistent enough that the exact contents of any given vial cannot be assumed

Aim for 25 to 35 grams of fiber a day

10.1200/JCO.2009.27.3730 174 MartinaJ